[{"data":1,"prerenderedAt":64},["ShallowReactive",2],{"q-nurse-113-2-basic-medicine-040":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":33,"lastmod":63},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"explanationDeep":23,"topics":24,"freq":26},"nurse-113-2-基礎醫學-040","nurse-113-2-basic-medicine-040",113,2,40,"有關克隆氏症（Crohn’s disease）之治療，下列那一個藥物屬於 TNF-α 抑制劑？",{"A":15,"B":16,"C":17,"D":18},"adalimumab","vedolizumab","ustekinumab","tofacitinib","A",null,[],"本題考點在於克隆氏症生物製劑的作用標的分類。依免疫藥理，adalimumab 為抗腫瘤壞死因子 α（TNF-α）的單株抗體，中和促發炎的 TNF-α 以控制克隆氏症的腸道發炎，故選 A。B vedolizumab 作用於 α4β7 整合素阻斷淋巴球歸巢。C ustekinumab 針對 IL-12\u002FIL-23 的 p40 次單元。D tofacitinib 為 JAK 激酶抑制劑，三者標的皆非 TNF-α。","發炎性腸道疾病生物製劑分類記憶：抗 TNF-α（infliximab、adalimumab、golimumab、certolizumab）、抗整合素（vedolizumab 腸道選擇性）、抗 IL-12\u002F23（ustekinumab）、小分子 JAK 抑制劑（tofacitinib）。使用抗 TNF 前須篩檢潛伏結核與 B 肝，因免疫抑制易致再活化。",[25,27,29,31],{"term":15,"count":26},1,{"term":28,"count":26},"TNF-α 抑制劑",{"term":30,"count":26},"克隆氏症生物製劑",{"term":32,"count":26},"生物製劑作用標的分類",[34,38,43,48,53,58],{"webId":35,"stem":36,"number":37,"year":10,"session":11},"nurse-113-2-basic-medicine-041","有關細菌內毒素（endotoxin），下列敘述何者最不適當？",41,{"webId":39,"stem":40,"number":41,"year":42,"session":26},"nurse-114-1-basic-medicine-037","下列何種藥物最適合以吸入方式用於緩解急性氣喘（asthma）發作？",37,114,{"webId":44,"stem":45,"number":46,"year":42,"session":47},"nurse-114-3-basic-medicine-031","下列藥物中，何者為前驅藥物（prodrug）需要體內酵素代謝才會產生活性，但有些人可能因其代謝酵素活性較低，而使得該藥物之藥效減弱？",31,3,{"webId":49,"stem":50,"number":51,"year":52,"session":26},"nurse-106-1-basic-medicine-079","立克次體與病毒相似的特性為何？",79,106,{"webId":54,"stem":55,"number":56,"year":57,"session":11},"nurse-107-2-basic-medicine-043","關於克隆氏病（Crohn disease）的敘述，下列何者正確？① 多侷限在迴腸（ileum）末端，也會侵犯結腸（colon） ②潰瘍十分表淺 ③潰瘍與潰瘍之間的正常黏膜有如鵝卵石般 ④常出現肉芽腫（granulomas） ⑤腸壁會變薄且嚴重擴大",43,107,{"webId":59,"stem":60,"number":61,"year":62,"session":11},"nurse-108-2-basic-medicine-077","下列關於感染結核分枝桿菌（Mycobacterium tuberculosis）的敘述，何者正確？",77,108,"2026-09-04",1788510754238]